Dalibor Valík
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Genetics top 10%
- Glioma Diagnosis and Treatment
Papers in
- Oncology 19
- Cancer Immunotherapy and Biomarkers 6
- CAR-T cell therapy research 5
- Immunology 13
- Immunotherapy and Immune Responses 5
- Co-authors
- Jaroslav Štěrba (26 shared papers)Lenka Zdražilová Dubská (29 shared papers)Regina Demlová (17 shared papers)Michael Allen Sheard (2 shared papers)Viera Bajčiová (8 shared papers)Bořivoj Vojtěšek (12 shared papers)Rostislav Vyzula (7 shared papers)Rudolf Nenutil (9 shared papers)
- Journals
- Annals of Oncology (4 papers)Oncology (3 papers)Frontiers in Oncology (3 papers)Clinical Chemistry (3 papers)Journal of Pediatric Hematology/Oncology (2 papers)
- Partner nations
- CzechiaUnited StatesGermany
In The Last Decade
Dalibor Valík
74 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 99
- Cancer Research 188
- Genetics 127
- Oncology 255
- Immunology 141
- Molecular Biology 434
Countries citing papers authored by Dalibor Valík
This map shows the geographic impact of Dalibor Valík's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dalibor Valík with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dalibor Valík more than expected).
Fields of papers citing papers by Dalibor Valík
This network shows the impact of papers produced by Dalibor Valík. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dalibor Valík. The network helps show where Dalibor Valík may publish in the future.
Co-authors
The 25 scholars most cited alongside Dalibor Valík, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 120 | |
| 2 | 2008 | 88 | |
| 3 | 2002 | 87 | |
| 4 | 2004 | 62 | |
| 5 | 2012 | 61 | |
| 6 | 2006 | 60 | |
| 7 | 2022 | 52 | |
| 8 | 2006 | 50 | |
| 9 | 2014 | 46 | |
| 10 | 2008 | 32 | |
| 11 | 2008 | 30 | |
| 12 | 2016 | 26 | |
| 13 | 2009 | 22 | |
| 14 | 2020 | 22 | |
| 15 | 1997 | 22 | |
| 16 | 2005 | 22 | |
| 17 | High-dose methotrexate and/or leucovorin rescue for the treatment of children with lymphoblastic malignancies: do we really know why, when and how? | 2005 | 21 |
| 18 | 2015 | 20 | |
| 19 | 2015 | 18 | |
| 20 | 2020 | 18 |
About Dalibor Valík
Dalibor Valík is a scholar working on Oncology, Immunology, Clinical Biochemistry, Spectroscopy and Cancer Research, having authored 76 papers that have together received 1.2k indexed citations. Recurring topics across this work include Mass Spectrometry Techniques and Applications (6 papers), Acute Lymphoblastic Leukemia research (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), CAR-T cell therapy research (5 papers), Advanced Proteomics Techniques and Applications (5 papers), Childhood Cancer Survivors' Quality of Life (5 papers), Metabolism and Genetic Disorders (5 papers) and Immunotherapy and Immune Responses (5 papers). The work is most often cited by research in Cancer Research (188 citations), Genetics (127 citations), Oncology (255 citations), Immunology (141 citations) and Molecular Biology (434 citations). Dalibor Valík has collaborated with scholars based in Czechia, United States and Germany. Frequent co-authors include Jaroslav Štěrba, Lenka Zdražilová Dubská, Regina Demlová, Michael Allen Sheard, Viera Bajčiová, Bořivoj Vojtěšek, Rostislav Vyzula, Rudolf Nenutil, Zdeněk Pavelka and Ladislav Dušek. Their work appears in journals such as Annals of Oncology, Oncology, Frontiers in Oncology, Clinical Chemistry and Journal of Pediatric Hematology/Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.